kabutan

Medrx, Jul-Sep (3Q) Net Income Loss Narrows

Fri Nov 14, 2025 3:30 pm JST Earnings

4586 Medrx Co.,Ltd. 【J-GAAP】

Earnings Report

Medrx Co.,Ltd. <4586> [TSE Growth] announced its financial results after the market closed on November 14th (15:30). The consolidated net loss for the cumulative third quarter of the fiscal year ending December 2025 (January to September) expanded to a loss of 769 million yen (compared to a loss of 320 million yen in the same period last year).

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated net loss for the October to December period (4Q) is expected to expand to a loss of 581 million yen (compared to a loss of 486 million yen in the same period last year).

In the most recent three-month period, from July to September (3Q), the consolidated net loss improved to a deficit of 140 million yen (compared to a loss of 259 million yen in the same period last year). The operating profit/loss margin improved from -1016.7% in the same period last year to -133.0%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jan - Sep, 2023 29 -670 -668 -671 -20.0 ー Nov 10, 2023 J-GAAP
Jan - Sep, 2024 255 -379 -343 -320 -7.6 ー Nov 8, 2024 J-GAAP
Jan - Sep, 2025 118 -742 -757 -769 -14.8 ー Nov 14, 2025 J-GAAP
YoY -53.7% -95.8% -120.7% -140.3% -95.3%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2024 26 -658 -671 -745 -17.2 0 Feb 14, 2025 J-GAAP
Jul - Dec, 2025 Guidance 104 -726 -712 -721 -12.1 0 Aug 8, 2025 J-GAAP
YoY +300.0% -10.3% -6.1% +3.2% +29.3%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 29 -933 -930 -932 -26.8 0 Feb 9, 2024 J-GAAP
Dec, 2024 257 -793 -755 -806 -18.6 0 Feb 14, 2025 J-GAAP
Dec, 2025 Guidance 122 -1,335 -1,335 -1,350 -22.7 0 Feb 14, 2025 J-GAAP
YoY -52.5% -68.3% -76.8% -67.5% -22.5%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2024 24 -244 -259 -259 -6.2 -1,016.7 Nov 8, 2024 J-GAAP
Oct - Dec, 2024 2 -414 -412 -486 -11.2 -20,700.0 Feb 14, 2025 J-GAAP
Jan - Mar, 2025 2 -419 -422 -429 -9.0 -20,950.0 May 9, 2025 J-GAAP
Apr - Jun, 2025 16 -190 -201 -200 -4.1 -1,187.5 Aug 8, 2025 J-GAAP
Jul - Sep, 2025 100 -133 -134 -140 -2.7 -133.0 Nov 14, 2025 J-GAAP
YoY +316.7% +45.5% +48.3% +45.9% +56.1%

Related Articles